Serum-free media have been shown to be effective in the expansion of mesenchymal stem cells (MSCs). However, the effects may go beyond cell expansion as the differentiation potentials of the cells may be modified, thus influencing their efficacy for downstream applications. The latter is poorly understood, and this has prompted an evaluation of the influence of a serum-free formulation on the chondrogenic, adipogenic, and osteogenic potential of MSCs. The media consisted of Knockout TM Serum Replacement (KSR) with a cocktail of growth factors coupled with either collagen or fibronectin coatings. Collagen coating was selected as it promoted consistent cellular attachment. When compared against fetal bovine serum (FBS) controls, cell proliferation in the serum-free media was enhanced at passage 1. Similar levels of surface markers were observed in the two groups with a slight reduction in CD90 and CD73 in the serum-free culture at passage 3. The cultures were screened under differentiation conditions and a better maintenance of the chondrogenic potential was noted in the serum-free media with higher expressions of glycoaminoglycans (GAGs) and collagen II. Chondrogenesis was deficient in the FBS group and this was attributed to the inherent inconsistency of animal serum. Adipogenesis was enhanced in the serum-free group with a higher PPARG expression and lipid accumulation. Similar levels of osteogenic mineralization was noted in the FBS and serum-free groups but collagen I gene expression was suppressed in the latter. This was initially observed during expansion. These observations were attributed to the signaling cascades triggered by the cytokines presented in the serum-free formulation and the interaction with the collagen substrate. The serum-free media helps to maintain and enhance the chondrogenic and adipogenic potentials of the MSCs, respectively. This advantage can be exploited for therapeutic applications in cartilage and adipose tissue engineering.
INTRODUCTION
Bonfield et al. has also demonstrated that MSCs were able to suppress chronic airway inflammation associated with the murine ovalbumin model of asthma and this The discovery of mesenchymal stem cells (MSCs) by Friedenstein was a major accomplishment in cellular was attributed to the anti-inflammatory molecular signals expressed by the stem cells (7) . The expression of therapeutics (18) . This multipotent cell was initially identified in bone marrow, and the International Society such molecular cues enables MSCs to influence other cell types. The homing and proliferation of hematopoifor Cellular Therapy (ISCT) has characterized it as a plastic adherent fibroblast-like clonogenic cell with etic stem cells (HSCs) within the bone marrow niche is influenced by MSCs (44) . Through cocultures, MSCs CD73, CD90, and CD105 surface antigens. MSCs lack CD34 and CD45 human leukocyte markers (31) . Recent were found to support vasculature formation from endothelial progenitor cells (16). These reparative cells were research has shown that the secretory activity of MSCs can be exploited for therapeutic applications such as the capable of systemic migration and they home in on sites of injury such as myocardial infarction with stromal immunosuppression of T cells, antiscarring, angiogenesis, antiapoptosis, and mitosis. Jeon et al. observed that cell-derived factor (SDF)-1α and integrins forming part of this migratory mechanism (20, 46, 73) . Besides bone conditioned media from MSCs enhanced the survival of fibroblast cells and the secretion of collagen, elastin, and marrow, MSCs were found in a range of tissues that include Wharton jelly (12) , placenta (60), amniotic fluid fibronectin (29). Thus, MSC stimulation could assist skin wound healing. (13) , adipose tissue (84) , and skin dermis (71) . The lat-est literature has even shown that MSCs reside as periblasts (CFU-F) were larger and more numerous when compared to FBS cultures. This was mainly due to the cytes in the perivascular location of various tissues (17) .
Intensive research was conducted to exploit the osincrease in DNA replication with the suppression of differentiation during expansion and it was attributed to the teogenic, adipogenic, and chondrogenic potential of MSCs in regenerative medicine. Osseous regeneration effects of platelet-derived growth factor (PDGF), fibroblast growth factor 2 (FGF2), vascular endothelial was one of the earliest avenues. Nonhealing segmental bone defects were bridged with MSCs seeded on scafgrowth factor (VEGF), and epidermal growth factor (EGF) (35, 42, 43, 68) . Tsutsumi and others noted that the folds (34, 56) . Enhanced regeneration at calvarial defects was achieved with porous matrices implanted with addition of FGF2 boosted the life span of MSCs during expansion due to an early telomere extension (5, 85) . MSCs (70). The stem cells can also be harnessed in the gene therapy of osteogenesis imperfecta (61) . Wakitani When Chung et al. injected chemotactic PDGF into a growth plate defect, he noted an increased MSC influx et al. (87) and Lee et al. (36) advocated its use for cartilage repair as MSCs are capable of differentiating into into the site (10) . EGF was reported to regulate bone homeostasis by suppressing MSC differentiation (88) . chondrocytes. Moreover, the cell could home in on the cartilage defect to exert a reparative response (36) . The
The advantage of platelet lysate arises from the presence of these cytokines but it is countered by constitutional need for soft tissue fillers is a constraint in plastic and reconstructive procedures. Cui et al. (11) and Neubauer variations between platelet donors, which leads to an inconsistent outcome in MSC cultures (69) . This could be et al. (53) attempted to resolve this via an MSC-based adipose tissue engineering approach. But stem cells are partially resolved with an optimal platelet concentration of 1.5 × 10 9 /ml that was pooled from at least 10 donors presented at low frequency even within the bone marrow; hence, monolayer culturing is needed so as to yield (35) . But this approach would strain the limited blood banking resources (35) . Hence, there is an impetus to significant numbers for therapeutic use. Unfortunately, conventional ex vivo expansion requires fetal bovine sedevelop an "off the shelf" serum-free media consisting of cytokines. rum, which is a worrisome concern.
Fetal bovine serum (FBS) is commonly used in cell Cancedda et al. submitted a patent on an MSC serumfree formulation that contained EGF, PDGF, FGF2, leucultures but it is a complex mixture with only 200 components identified. The biochemical effects of these kemia inhibitory factor (LIF), stem cell factor (SCF), and dexamethasone (8) . But poor cell attachment has molecules remain undefined and the composition varies between serum batches, thus leading to inconsistent outprompted the inclusion of FBS for initial plating (8) . Pal et al. (59) and Shetty et al. (75) encountered the same comes that can only be prevented via tedious prescreening (54). Moreover the presence of viruses, prions, and limitation with serum-free media and cord blood serum, respectively. Hence Pal et al. concluded that these altermycoplasmas presents a safety concern. Animal serum also introduces xenogenic antibodies that can cause senatives could only maintain ongoing cultures that were already isolated using FBS (59). However, this could be vere anaphylactic or arthus-like immune reactions (72 (40) . The unwere rinsed with sterile phosphate-buffered saline (PBS). Hcol and Hfn serum-free cultures were evaluated derstanding of these phenomena was hindered by the undisclosed composition of the commercial product, against FBS controls and cell adhesion was monitored via microscopy. Confluent cultures were trypsinized hence troubleshooting was difficult. This inevitably becomes an obstacle in the translational efforts for specific with 0.25% trypsin, which was removed via extensive PBS washings. After hemocytometer counts, the cells applications.
The present study was proposed to evaluate the effiwere plated at 10,000/cm 2 and this was repeated every week until passage 5 (P5). Fold increase was calculated cacy of MSCs expanded in serum-free media towards osteogenic, chondrogenic, and adipogenic differentiaby dividing the cell counts of each passage by the number of seeded cells. P2 and P3 cultures were subjected tions. This would gauge the effect of the serum-free medium on downstream musculoskeletal applications. The to flow cytometry while basal gene expression during expansion was scrutinized. Moreover, P3 cells were exmedium of interest consisted of Knockout TM Serum Replacement (KSR, Invitrogen, Carlsbad, CA), FGF-2, posed to chondrogenic, osteogenic, and adipogenic inductions. EGF, PDGF-AB, and dexamethasone. KSR was originally developed for embryonic stem cells (ESCs) (92).
Chondrogenic cultures were initiated by centrifuging aliquots of 0.25 million cells at 150 × g for 10 min in The serum-free alternative was coupled with either human recombinant fibronectin (Hfn) or collagen I (Hcol).
15-ml polypropylene conical tubes. These pellets were maintained for 28 days with 100 nM dexamethasone, MSC attachment, proliferation, surface antigens, and basal gene expressions were scrutinized during the 1% ITS+ premix (Biomedical Diagnostics, Ann Arbor, MI), 50 µg/ml ascorbic acid, 1 mM sodium pyruvate expansion phase. Subsequently, osteogenic, chondrogenic, and adipogenic differentiations were assessed rel-(Invitrogen), 4 mM proline, 2 mM L-glutamine (Invitrogen), 100 U/ml penicillin-streptomycin (Invitrogen), and ative to FBS controls.
high glucose DMEM. Chondrogenic induction was MATERIALS AND METHODS achieved with 10 ng/ml of transforming growth factorReagents and Chemical β3 (TGF-β3, R&D systems, Minneapolis, MN), which was omitted from the uninduced controls. Osteogenic Unless otherwise stated, all reagents were purchased potential was evaluated in cultures plated at 3000/cm 2 , from Sigma Aldrich (St. Louis, MO). High and low glumaintained for 21 days in 10 nM dexamethasone, 50 µM cose Dulbecco's modified Eagle's medium (DMEM) ascorbic acid, 10 mM β-glycerophospate, 10% FBS, 100 was from Gibco BRL (Grand Islands, NY). All labware U/ml penicillin-streptomycin, and high glucose DMEM. consumables were purchased from Becton-Dickinson Uninduced controls were kept in the FBS expansion me-(Franklin Lakes, NJ). dia. Adipogenic induction was achieved by seeding MSC Culture and Differentiation MSC at 30,000/cm 2 and maintained for 21 days in high glucose DMEM, 10% FBS, 100 U/ml penicillin-streptoBone marrow was aspirated from the posterior iliac crest of patients who were undergoing elective orthopemycin (Invitrogen), 2 mM L-glutamine (Invitrogen), 0.01 mg/ml insulin (Invitrogen), 0.02 mM indomethacin, dic procedures. Patient consent was granted and the work was approved by the Hospital Institutional Review 1 µM dexamethasome, and 0.5 mM 3-isobutyl-1-methylxanthine. Board. Equal volumes of bone marrow were plated either in FBS-supplemented or serum-free medium. The
Flow Cytometry FBS culture consisted of low glucose DMEM, 10% FBS (Invitrogen, Carlsbad, CA), and 100 U/ml penicillinSaturating concentrations of fluorescein osothiocyanate (FITC), phycoerythrin (PE), or phycoerythrin Cy5 streptomycin (Invitrogen). The serum-free alternative contained low glucose DMEM, 10% KSR (Invitrogen), (PE-Cy5) conjugated monoclonal mouse antibodies were incubated with 100,000 P2-P3 cells in the dark 2 ng/ml FGF2, 2 ng/ml EGF, 2 ng/ml PDGF-AB (Peprotech, Rocky Hill, NJ), 10 nM dexamethasone, and 100 at room temperature for 30 min. Appropriate isotypematched controls were included. Washing was per-U/ml penicillin-streptomycin (Invitrogen). The concentrations of these components had been optimized from formed with a buffer containing 0.1% sodium azide, 4% FBS, and PBS. The cells were suspended in fresh buffer prior studies. Cell plating in the serum-free medium was assisted either with Hcol (100 µg/cm (Beckman Coulter) for the following markers: CD90-lagen I (dilution factor 1:500), collagen II (Chemicon, Temecula, CA; dilution factor 1:500), collagen X (Quar-PE-Cy5, CD73-PE, CD45-PE-Cy5, CD44-FITC, and CD29-PE (BD Biosciences, San Jose, CA).
tett, Berlin, Germany; dilution factor 1:25), and aggrecan (Abcam, Cambridge, MA; dilution factor 1:100) Real-Time Polymerase Chain Reaction (PCR) primary antibodies. Isotype controls (Dakocytomation, Glostrup, Denmark) were included. Endogenous peroxiGene expressions of collagen I, sex-determining redase was blocked with hydrogen peroxide. Antigen region Y Box-9 (Sox9), runt-related transcription factor 2 trieval was performed via a 20-min pepsin treatment (Runx2), and peroxisome proliferator-activated receptor (Labvision, Fremont, CA). Biotinylated goat anti-mouse gamma (PPARG) were evaluated during MSC expansecondary antibodies (Labvision, Fremont, CA) were sion, osteogenic and adipogenic inductions at day 14.
added at room temperature for 30 min. Streptavidin per-RNA was extracted using Trizol (Invitrogen) and RNeasy oxidase was administered for 45 min with the use of Mini kit (Qiagen, Chatsworth, CA). Total RNA was 3,3′-diaminobenzidine as a chromogenic agent. Countermeasured via NanoDrop (Nanodrop Technologies, Wilstaining was done with Gill's hematoxylin, after which mington, DE). Reverse transcription was achieved with the sections were dehydrated before being cover slipped. 100 ng of RNA via the iScript TM cDNA synthesis kit Mineralization in the osteogenic cultures was de-(Biorad, Hercules, CA). Real-time PCR was performed tected with 2% Alizarin red. The staining was quantified using the SYBR green system (7500 real-time PCR systhrough 10% hexadecylpyridinium chloride elution with tem, ABI, Foster city, CA). Amplifications for cDNA absorbance measured at 562 nm. Oil red stained the lipid were carried out at 50°C for 2 min, 95°C for 10 min, deposits in the adipose induced samples. Dye extraction followed by 40 cycles at 95°C for 15 s and 60°C for a was performed using 100% isopropanol and absorbance min. Primer sequences are as shown in Table 1 . Fold was measured at 510 nm. change in gene expression was calculated using the 2 −∆∆Ct
method. The gene expression was first normalized to
Quantitative Assay for Chondrogenesis glyceraldehyde 3-phosphate dehydrogenase (GAPDH) within each sample group. Subsequently, the values Cellularity, GAGs, collagen I, and collagen II in the were normalized against the passage 1 FBS controls.
chondrogenic pellet cultures were measured using PicoGreen (Invitrogen), dimethymethylene blue (DMMB), Histology and Immunohistochemistry enzyme-linked immunosorbent assay against collagen I and II (ELISA, Chondrex, Redmond, WA), respectively. Day 28 chondrogenic pellets were evaluated via histology and immunohistochemistry. The samples were Chondrogenic pellets were washed in PBS and digested in 1 mg/ml pepsin and 0.1 mg/ml pancreatic elastase. fixed overnight in 10% neutral buffered formalin, dehydrated, and embedded in paraffin. Sections (5 µm) were Once solubilized, the samples were centrifuged and the supernatant was kept aside. DNA content was measured taken from the center, deparaffinized, and hydrated. Glycosaminoglycans (GAGs) were stained with 0.5% via the PicoGreen DNA quantification kit with the aid of a Tecan microplate reader (Männedorf, Switzerland). Alcian blue. Immunohistology was conducted using col- I NM_000088  5′-CAG CCG CTT CAC CTA  5′-TTT TGT ATT CAA TCA CTG  83 bp  CAG C-3′  TCT TGC C-3′  Sox9  NM_000346  5′-CAG TAC CCG CAC TTG  5′-CTC GTT CAG AAG TCT CCA  69 bp  CAC AA-3′  GAG CTT-3′  Runx2  NM_004348  5′-AAC CCA CGA ATG CAC  5′-CGG ACA TAC CGA GGG  76 bp  TAT CCA-3′  CAA TG-3′  PPARG  NM_138711.3 5′-TGT CTC ATA ATG CCA TCA  5′-CGC CAA CAG CTT CTC  62 bp  GGT TTG-3′  CTT CT-3′  GAPDH  NM_002046  5′-ATG GGG AAG GTG AAG  5′-TAA AAG CAG CCC TGG  70 bp  GTC G-3′ TGA CC-3′
Sox9: sex-determining region Y box-9; Runx2: Runt-related transcription factor 2; PPARG: peroxisome proliferator-activated receptor gamma; GAPH: glyceraldehyde 3-phosphate dehydrogenase.
GAG measurements were derived from DMMB absorbetween patient samples were high, as shown by the large standard deviations in Figure 2 . Therefore, the data bance readouts, which were compared against that of chondroitin-6-sulfate standards. The amounts of collasuggested a potentially different response from the two cultures during chondrogenic and adipogenic inductions. gen I and collagen II presented in each sample were measured in accordance to the Chondrex ELISA kit proMoreover, the secretion of collagen I might also differ. Such discrepancies were attributed to the cytokines pretocol.
sented in the serum-free media, which triggered signaling cascades, modulating the differentiation pathways.
Statistical Analysis
During chondrogenic induction, GAGs was syntheAll quantitative data garnered from the samples taken sized in the MSC pellets as indicated by the positive from four patients were analyzed using Student t-test Alcian blue staining (Fig. 3A, E) . The FBS pellets with p < 0.05 being considered for significant differstained strongly for collagen I but weakly for collagen ence. Replications were conducted for each experimen-II (Fig. 3B, C, F, G) . Cellularity, GAGs, collagen I, and tal group.
collagen II in the chondrogenic pellets were quantified by PicoGreen, DMMB assay, and ELISA, respec-RESULTS tively. It was observed that the Hcol pellet was less cellular with a lower total collagen I, but higher total GAGs Bone marrow was plated equally in FBS, Hcol, and Hfn serum-free media. Cell attachment was observed on and collagen II levels. When these measurements were normalized to DNA, it was discovered that GAGs and Hcol and it was comparable to the FBS control (Fig. 1A,  B) . Unfortunately, this was not the case for Hfn even collagen II deposition per cell was reduced in the FBS control (Fig. 3M, O) . This was not the case for collagen after 14 days of seeding (Fig. 1C) ; hence, the coating was omitted from further investigations. Hcol and FBS I as the normalized values were equivalent for both groups (Fig. 3N ). In addition, chondrogenic, osteogenic, cells were fibroblastic as observed in P1 to P5 (Fig. 1D-M) . Cell proliferation was significantly promoted in the and adipogenic potentials were also evaluated. After 21 days of osteogenic induction, mineralization was obHcol group at P1, but this did not arrest the general decline in proliferation as the fold increase dropped after served in the two cultures as indicated by Alizarin red staining and it was comparable given the similar absoreach passage (Fig. 1N) . However, there was a net increase in cell numbers as the cell counts derived at the bance of the extracted dye (Fig. 3S) . However, collagen I gene expression was significantly suppressed in the end of each passage exceeded the initial number of seeded cells. MSC surface markers CD90, CD73, CD44, Hcol group during osteogenic induction (Fig. 3R) . Conversely, PPARG was upregulated in the Hcol sample and CD29 were detected in both groups at P2 and P3 (Fig. 1O) . But CD45, which is a leukocyte marker, was and this adipogenic enhancement was demonstrated by the increased lipid accumulation as shown by oil red absent from the isolated cells. Hence, the MSC progenitor status was maintained under serum free conditions staining and quantification. There was considerable MSC donor variation, which and it was comparable to the FBS group. But there was a significant reduction (p < 0.05) in the number of CD90-led to large deviations in the numerical data. This was particularly so for chondrogenic differentiation. Despite and CD73-positive cells when the Hcol culture transited from P2 to P3. This might be attributed to the effects of that, trends were noted. The Hcol samples displayed higher levels of chondrogenic markers than the FBS the serum-free culturing and the cytokines presented in the media.
group. This was supported by the histological staining, which indicated positive collagen II staining for all four Mesenchymal differentiation might be affected by the preceding serum-free conditions. This could be eluciHcol pellets. Conversely, three out of four FBS samples failed to stain for this critical marker (Fig. 4A, C) . Furdated from the basal gene expression of Sox9, Runx2, and PPARG, which were crucial markers for chondrothermore, the Hcol pellets registered higher levels of aggrecan as shown by immunostaining (Fig. 4B, D) . genesis, osteogenesis, and adipogenesis, respectively. The expression of collagen I was also assessed and it Basal gene expression analyzed during the expansion suggested differences in mesenchymal differentiation was found to be significantly lower in the Hcol cells from P1 to P5 (Fig. 2A) . This trend was similarly obbetween the FBS and Hcol cultures. Although Sox9 was lower in the later group, Hcol MSC chondrogenesis was served for Sox9 except at P1 (Fig. 2B) . Runx2 gene expression was not significantly different for both groups enhanced, as shown by the superior collagen II and GAGs secretions. Furthermore, only one out of the four but it seemed to peak at P3 in the serum-free culture (Fig. 2C) . Conversely, there was higher PPARG expres-FBS samples expressed collagen II during chondrogenic differentiation. But all these donor cells were capable sion in the Hcol group across all passages (Fig. 2D) . Such trends were observed even though the variations of doing so if maintained under serum-free conditions. Cytokines presented in the serum alternative might have DISCUSSION enhanced proliferation while suppressing chondrogenic pathways during expansion. Sox9, a key molecular The serum-free media supported cellular growth. Cells adhered on the Hcol coating but deficiently on switch in the chondrogenic signaling cascade, was implicated as it was lower in the Hcol group. But this was Hfn. Hence, the latter was deemed unsuitable and omitted from further studies. Cell proliferation in the Hcol only temporary. During induction, a reversal happened with the upregulation of chondrogenic pathways and the group was three times that of the FBS culture at P1 and this would mean that a larger number of serum-free excurtailment of proliferation. Hence, the Hcol pellets were less cellular than the FBS specimens and they conpanded cells could be obtained at an earlier stage, thus avoiding the risk of malignant transformation and senestained higher levels of GAGs and collagen II. In contrast, adipogenic potential was upregulated from the cence, which are prevalent at the late passages (38, 94) . This proliferation enhancement was only observed at P1, very onset of serum-free expansion. This was maintained during induction with superior MSC lipid accuprobably due to the receptivity of the early cultures to the mitogenic effects of the serum-free environment. mulation. There were no differences between the two osteogenic cultures as there was similar calcification.
Surface antigen profiling identified the Hcol cells as MSCs because they were positive for CD90, CD73, The findings would suggest the presence of chondrogenic inhibitors or inadequate supportive cues in FBS.
CD44, and CD29 but negative for CD45. However, it should be noted as there was a decline in the expression Conventionally, MSC cultured with FBS could differentiate into collagen II synthesizing chondrocytes. The of CD90 and CD73 when the cells were passaged. This was attributed to the biochemical effects of the serumpaucity of this key ECM marker in the FBS pellets was due to the compositional inconsistency between FBS free media as it was not observed in the FBS control. Interestingly, the decline was not associated with a downbatches. This could be resolved via serum-free expansion, which was supportive of cartilage and adipose reregulation of the differentiation potentials of the serumfree cultures. This was similarly observed when Shih et generative applications. However, there were reservations pertaining to the use of the formulation in osseous al. (76) and Sanchez-Guijo et al. (67) isolated MSCs from the parathyroid gland and trabecular bone, respectherapies given the deficient expression of collagen I, which is an essential bone ECM protein.
tively, and they noted differing CD90 expressions with Quantitative analysis indicated high cellularity in the FBS pellet (I) with lower total GAGs (J) and collagen II (L) compared to the serum free group. This was similarly observed with the DNA normalized values (M, O). There was enhanced GAGs and collagen II synthesis per cell maintained under the serum-free conditions. Conversely, the FBS group has a higher total collagen I (K) but the DNA normalized value was equivalent for both groups (N). The Hcol MSC exhibited enhanced chondrogenic differentiation compared to the FBS culture. Mineralization was observed in the FBS and Hcol groups with Alizarin red (P, Q). There was a lower collagen I gene expression in the Hcol culture (R) but calcification levels were equivalent in both groups (S). Lipid accumulation was observed in the cells under adipogenic induction as shown by oil red (T, U). However, adipogenesis was superior in the Hcol culture with higher PPARG gene expression (V) and higher lipid content (W). All controls stained negatively. *Significant difference between FBS and Hcol (p < 0.05, N = 4). respect to bone marrow-derived MSCs. Despite that, the by the ligand in the serum-free environment. This was circumvented with collagen I, which possesses an intestem cells maintained the ability to undergo chondrogenic, adipogenic, and osteogenic differentiations. Thus, grin-binding domain and this substrate was employed in the conservation of chondrocytic phenotype in an earlier cell surface marker profiling may not be adequate to elucidate the differentiation capability of MSCs; therefore, study (23) . Barbero et al. (3) were able to improve the expression of GAGs and collagen II when they seeded differentiation studies are required.
Surface coating assisted MSC serum-free expansion, chondrocytes on collagen coatings in a cytokine-enriched media. They reasoned that the enhancement was due to as cell isolation was poor in the absence of the substrate (results not shown). Biomaterials such as gelatin, fibrothe interactions between the natural substrate and cell surface receptors, which promoted the chondrogenic nectin, and collagen promote cellular adhesion by mimicking certain aspects of the natural ECM. The primitive pathway. Similarly, the collagen coating might have stimulated the chondrogenic potential of the serum free progenitor status of MSCs could be maintained on a gelatin substrate in a serum-free environment (4). Fibronecgroup as shown in the data.There were various attempts in developing an MSC serum-free formulation with cell tin is found in the provisional matrix of wounds and it encourages cell migration (89). Hence, it has been freproliferation as the prime focus. Although these cells were capable of chondrogenic, osteogenic, and adipoquently used as a cell adhesion coating. Interestingly, this effectiveness was not demonstrated under serumgenic differentiations, the efficacies of each lineage might be modulated by the constituents of the serumfree conditions and it was likely that fibronectin must be complemented with other bioactive components for it free media. This was witnessed in the present study. During expansion, basal gene expression revealed differto facilitate cell attachment effectively. In addition, the necessity of fibronectin for cell attachment was doubted ences in the chondrogenic and adipogenic potentials of FBS and Hcol cultures. Sox9 and PPARG mRNA levels by Steele et al. (80) when they observed a mere 20% reduction in epithelial cell attachment in fibronectindiffered between the two cultures, but Runx2 was not significantly different, thus hinting of an equivalent osdepleted FBS supplemented cultures. They suspected that there were other more critical prerequisites for celteogenic capacity. When the basal gene expressions were examined against actual differentiations, chondrolular adhesion. The current findings reinforced this suspicion as MSCs attached poorly on Hfn, probably begenic, osteogenic, and adipogenic capacities were inverted, maintained, or enhanced, respectively, during cause the essential signaling cascades were not triggered serum-free expansion and induction.Chondrogenic difpretreated MSC cultures with 100 nm of dexamethasone, there was an increase expression of alkaline phosferentiation appeared to be suppressed in the Hcol serum-free cultures (P2-P5) given the lower Sox9 gene phatase and osteocalcin (58) . However, Ito et al. commented that dexamethasone (1-1000 nM) was unable expression. However, the contrary happened as the chondrogenic-induced Hcol pellets registered higher levto sustain terminal differentiation given the absence of osterix, which is a late osseous marker (27) . This could els of chondrocytic ECM markers such as GAGs and collagen II. Despite using the same donors, collagen II be overcome by the complementary use of 2.5 ng/ml of FGF2 (19). But FGF2 on its own seems to inhibit was prevalent in all the Hcol samples but only one FBS pellet. Hence, chondrogenesis was enhanced in the Hcol osteogenesis in a reversible, dose-dependent manner (65) . Therefore, in an enriched cytokine environment, group even though the basal Sox9 gene expression suggested otherwise. It was probable that the chondrogenic complex biochemical interactions arise, leading to outcomes that are contrary to that expected of single growth pathway was suppressed during expansion with the upregulation of proliferative genes. But a reversal ocfactors. The osteogenic potential of the Hcol culture was unchanged despite the presence of dexamethasone and curred upon induction as there was a lower cell proliferation in the Hcol pellet, as shown by the lower DNA FGF2. This might be due to the inclusion of EGF and PDGF. Krampera et al. observed that EGF signaling led content. This was compensated by the enhanced deposition of chondrocytic ECM. The deficient chondrogenesis to self-renewal while suppressing differentiation during MSC expansion (33) . PDGF had a similar effect, but it in the FBS group mirrors the studies of Bilgen et al. (6) and Zaky et al. (93) , who were unable to solicit GAGs was expressed in osteoblasts during bone fracture repair (30,83). and collagen II productions in their FBS-expanded MSCs. But one must be mindful that such reports and Adipogenic potential was increased in the serum-free environment with improved responsiveness towards inthe present findings were contrary to the established protocol, whereby FBS expanded MSCs were shown to be ductive agents as shown by the high PPARG expression. Consequently, there was a higher level of lipid accumuable to undergo chondrogenesis upon induction. An example would be Yokogama et al.'s report, which indilation in the Hcol adipocytes compared to the FBS control. Neubauer et al. observed similar outcomes when he cated that high FBS content stimulated chondrogenic differentiation (91) . However, they cautioned that the pretreated MSCs with FGF2 (52). The combination of FGF2 and dexamethasone stimulated adipogenic differobservations might be subjective given the varying cytokine concentrations in the different FBS lots (91) . Thereentiation through a sarcoma tyrosine kinase (Src) mechanism (37) . Studies have shown that dexamethasone fore, it was likely such inconsistency was predominant in this study as the present batch of FBS used in the primes the progenitor cells for this lineage (27, 58) . Moreover, adipogenic differentiation was reported to be experiment was unable to maintain the chondrogenic status of the stem cell. This could be circumvented with induced with 100 nM of the glucocorticoid in the absence of other reagents (25) . a combination of growth factors in the serum-free media. MSC expansion with dexamethasone and FGF2 has
The upregulation of one signaling pathway can occur at the expense of another, especially so when there is been shown to promote in vitro chondrogenesis with increasing GAGs and collagen II expressions (9, 28, 78, 81) .
cross-talk. This intricate balance was maintained between adipogenesis and osteogenesis in the bone marWhen administered into rabbit cartilage defects, FGF2 stimulated chondroprogenitor expansion, thereby assistrow and it might be disrupted when specific MSC lineages are augmented artificially. Bone formation ining the regeneration of hyaline cartilage (21) . Fibrous repair was discovered when neutralizing monoclonal anvolves the activation of MSC osteogenic pathways, concomitant with an active suppression of adipogenesis tibodies were used against FGF2. Although the cytokine is mitogenic, Yanada et al. suggested a reversal during (51). PPARG is the regulator of interest and it is part of a complex signaling circuitry encompassing other fac-MSC chondrogenesis as there was extensive telomere shortening with FGF2 pretreatment (90) . This might extors such as bone morphogenic proteins (BMPs), wingless type MMTV integration site (Wnts), Runx2, and plain the poor cellularity of the Hcol pellets compared to the FBS controls.
FGF (51). Adipogenesis was suppressed in PPARG knockout mice while bone mass increased due to enOsteogenesis was similar in the FBS and Hcol cultures as shown by the equivalent mineralization. Mizuno hanced osteoblastogenesis (2,32). Conversely, PPARG expression was upregulated in premature aging animals et al. commented that the osteogenic differentiation of MSC was dependent on the quality of the FBS used durwith a decline in Runx2, thus resulting in fatty bone marrow (50). This compensatory mechanism was not ing expansion (49). Dexamethasone supplementation could resolve such inconsistencies as it activates Runx2, observed in the Hcol group despite its disposition towards adipogenesis, as the osteogenic potential was simhence stimulating osteogenesis (47 pooled human serum (63). However, a 40-fold increase in cell yield was achieved when EGF, PDGF, FGF2, to be a strong stimulator of both adipogenesis and osteogenesis. This cytokine promoted adipose generation dexamethasone, insulin, and macrophage colony stimulating factor (M-CSF) were added to the serum. Roche on collagen scaffolds seeded with preadipocytes; it also stimulated bone formation in osteopenic ovariectomized et al. used a similar approach to promote the differentiation efficiency of MSCs towards osteogenic and adiporats (22, 39) . Conversely, the exposure to FGF2 triggered a reduction of osteogenic markers in osteoblastic MC3T3-genic phenotypes under reduced serum conditions (66). Zaky et al. (93) and Lindroos et al. (40) managed to E1 cells while upregulating adipogenic genes (14) . Muruganandan et al. stressed that the effects of FGF was coax their cultures towards chondrogenesis by using platelet lysates and StemPro media, both containing determined by other stimuli (51).
Improved MSC proliferation and differentiation cytokines. Hence, it was possible to tailor MSC expansion in a serum-free manner towards specific clinical apcould arise from population selection. Previous studies were able to derive a subpopulation with high telomeplications. This serum-free approach was similarly applied to other cell types in liver and pancreas tissue rase activity via serum deprivation, and dexamethasone was thought to induce the apoptosis of cells with imregeneration (48,57). paired differentiation capacities (58, 62) . Esposito et al.
CONCLUSION tested this selection theory by plating bone marrow MSCs in supernatants extracted from bone fragments, MSCs were successfully isolated and expanded in a stroma, and embryonic fibroblast cell cultures (15) . Difnovel serum-free media. Differentiation studies revealed ferent subpopulations were isolated in each group and a disposition of the cells towards chondrogenesis and adipoprogenitors were enriched in the last supernatant.
adipogenesis. These findings demonstrate that it is posSimilarly, chondroprogenitors and adipoprogenitors might sible to cultivate MSCs in a serum-free environment be selected in the Hcol group under serum-free condiwhile enhancing the specific differentiation capacities. tions. But this suspicion could only be confirmed if a This dualistic approach not only eliminates the safety larger donor population was used as the authors acconcerns with regard to the use of FBS but it also tailors knowledged that a donor size of four was rather limited.
MSCs to suit applications in cartilage repair and adipose Interestingly, collagen I mRNA was significantly regeneration. This finding has not been reported conclulower in the serum-free group (P1-P5) and this was also sively before. The results represent a significant breakobserved during osteogenic induction. This could be atthrough for potential clinical use and warrants future in tributed to the addition of FGF2 in the serum-free forvivo studies. mulation, as Hurley et al. (26) not fully recapitulated in the pellet cultures; hence, collagen I was secreted in the samples. REFERENCES KSR has been used as a serum substitute in ESC and
